NCT01706224View on ClinicalTrials.gov

Sero-prevalence of Anti-pertussis Antibodies and Disease Awareness Among Spanish Healthcare Professionals

CompletedOBSERVATIONAL
Enrollment

757

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Pertussis
Interventions
PROCEDURE

Blood sample

Samples will be tested to determine the presence of anti-pertussis antibodies.

OTHER

Data collection

Electronic Case Report Forms (eCRF)

OTHER

Data collection

Questionnaires, active questioning.

Trial Locations (3)

15006

GSK Investigational Site, A Coruña

08907

GSK Investigational Site, L'Hospitalet de Llobregat

Unknown

GSK Investigational Site, Majadahonda

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01706224 - Sero-prevalence of Anti-pertussis Antibodies and Disease Awareness Among Spanish Healthcare Professionals | Biotech Hunter | Biotech Hunter